246 related articles for article (PubMed ID: 12796473)
1. The liberation of CD44.
Cichy J; Puré E
J Cell Biol; 2003 Jun; 161(5):839-43. PubMed ID: 12796473
[TBL] [Abstract][Full Text] [Related]
2. CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signals.
Orian-Rousseau V; Sleeman J
Adv Cancer Res; 2014; 123():231-54. PubMed ID: 25081532
[TBL] [Abstract][Full Text] [Related]
3. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
4. CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis.
Knudson W; Aguiar DJ; Hua Q; Knudson CB
Exp Cell Res; 1996 Nov; 228(2):216-28. PubMed ID: 8912714
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan and CD44: strategic players for cell-matrix interactions during chondrogenesis and matrix assembly.
Knudson CB
Birth Defects Res C Embryo Today; 2003 May; 69(2):174-96. PubMed ID: 12955860
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism.
Uff CR; Neame SJ; Isacke CM
Eur J Immunol; 1995 Jul; 25(7):1883-7. PubMed ID: 7542594
[TBL] [Abstract][Full Text] [Related]
7. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins.
Czekay RP; Aertgeerts K; Curriden SA; Loskutoff DJ
J Cell Biol; 2003 Mar; 160(5):781-91. PubMed ID: 12615913
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan and CD44: modulators of chondrocyte metabolism.
Knudson CB; Knudson W
Clin Orthop Relat Res; 2004 Oct; (427 Suppl):S152-62. PubMed ID: 15480059
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases.
Gee K; Kryworuchko M; Kumar A
Arch Immunol Ther Exp (Warsz); 2004; 52(1):13-26. PubMed ID: 15053229
[TBL] [Abstract][Full Text] [Related]
11. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
[TBL] [Abstract][Full Text] [Related]
12. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions.
Bajorath J
Proteins; 2000 May; 39(2):103-11. PubMed ID: 10737932
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of CD44 in regulating skeletal micrometastasis.
Hill A; McFarlane S; Johnston PG; Waugh DJ
Cancer Lett; 2006 Jun; 237(1):1-9. PubMed ID: 15979783
[TBL] [Abstract][Full Text] [Related]
14. Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain.
Liu D; Sy MS
J Immunol; 1997 Sep; 159(6):2702-11. PubMed ID: 9300690
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer.
Misra S; Hascall VC; Berger FG; Markwald RR; Ghatak S
Connect Tissue Res; 2008; 49(3):219-24. PubMed ID: 18661347
[TBL] [Abstract][Full Text] [Related]
16. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy.
Hibino S; Shibuya M; Engbring JA; Mochizuki M; Nomizu M; Kleinman HK
Cancer Res; 2004 Jul; 64(14):4810-6. PubMed ID: 15256450
[TBL] [Abstract][Full Text] [Related]
17. G1 domain of aggrecan cointernalizes with hyaluronan via a CD44-mediated mechanism in bovine articular chondrocytes.
Embry JJ; Knudson W
Arthritis Rheum; 2003 Dec; 48(12):3431-41. PubMed ID: 14673994
[TBL] [Abstract][Full Text] [Related]
18. CD44 family and gynaecological cancer.
Makrydimas G; Zagorianakou N; Zagorianakou P; Agnantis NJ
In Vivo; 2003; 17(6):633-40. PubMed ID: 14758731
[TBL] [Abstract][Full Text] [Related]
19. PKC-induced stiffening of hyaluronan/CD44 linkage; local force measurements on glioma cells.
Lamontagne CA; Grandbois M
Exp Cell Res; 2008 Jan; 314(2):227-36. PubMed ID: 17698062
[TBL] [Abstract][Full Text] [Related]
20. The non-coding 3' UTR of CD44 induces metastasis by regulating extracellular matrix functions.
Rutnam ZJ; Yang BB
J Cell Sci; 2012 Apr; 125(Pt 8):2075-85. PubMed ID: 22637644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]